Brookfield Asset Management Inc. Cytokinetics Inc Transaction History

Brookfield Asset Management Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	SELL	$35.77 - $51.11 $794,952 - $1.14 Million	-22,224 Reduced 22.25%	77,642 $3.56 Million
Q3 2022 Nov 14, 2022	BUY	$38.54 - $54.52 $1.93 Million - $2.73 Million	49,995 Added 100.25%	99,866 $4.84 Million
Q2 2022 Nov 16, 2022	SELL	$33.93 - $48.92 $1.7 Million - $2.45 Million	-49,995 Reduced 50.06%	49,871 $1.96 Million
Q2 2022 Aug 15, 2022	BUY	$33.93 - $48.92 $1.69 Million - $2.44 Million	49,871 New	49,871 $1.96 Million

410

125M

4.6M

2.43M

Ticker CYTK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,144,096
Market Cap $4.92B
Description
Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.